Juan David Figueroa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Juan David Figueroa has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Garrett Larson
City of Hope National Medical Center, Duarte, CA, USA
1 shared publication - Gonzalo Vásquez Palacio
Universidad de Antioquía
1 shared publication - Jeffrey Nelson Weitzel
The University of Kansas Cancer Center, Kansas City, MO, United States; Latin American School of Oncology, Sierra Madre, CA, United States
1 shared publication - Jorge Alberto Madrid Vélez
Clínica Las Américas, Medellín, Colombia
1 shared publication - Julián Esteban Londoño Hernández
Universidad de Antioquia, Grupo de Alergología Clínica y Experimental, Antioquia, Colombia.
1 shared publication - Marcia Llacuachaqui
Women’s College Research Institute
1 shared publication
Latest Publications
- Open Access
- 17 April 2014
- Published by Springer Nature in Hereditary Cancer in Clinical Practice
- Vol. 12 (1) , 11
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Medellín, Colombia
Approximately 5% of all breast cancers can be attributed to a mutation in the BRCA1 or BRCA2 gene. The genetic component of breast cancer in Colombia has been, for the most part, studied on cases from the Bogota region. Five different founder mutations have been identified in two studies of breast cancer patients in the Bogota region. It is important that the frequency of mutations be established among unselected cases of breast cancer of other regions of Colombia in order to estimate the genetic burden of this cancer in Colombia and to plan genetic services. The aim of this study was to establish the mutation frequencies of the BRCA genes in breast cancer patients unselected for family history or age, from Medellin, Colombia.
- 17 April 2014
- Published by Springer Nature in Hereditary Cancer in Clinical Practice
- Vol. 12 (1) , 11
Open AccessPrevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Medellín, Colombia
Approximately 5% of all breast cancers can be attributed to a mutation in the BRCA1 or BRCA2 gene. The genetic component of breast cancer in Colombia has been, for the most part, studied on cases from the Bogota region. Five different founder mutations have been identified in two studies of breast cancer patients in the Bogota region. It is important that the frequency of mutations be established among unselected cases of breast cancer of other regions of Colombia in order to estimate the genetic burden of this cancer in Colombia and to plan genetic services. The aim of this study was to establish the mutation frequencies of the BRCA genes in breast cancer patients unselected for family history or age, from Medellin, Colombia.